Status:
COMPLETED
A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device
Lead Sponsor:
Syntara
Conditions:
Healthy
Bronchiectasis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
A novel dry powder inhaler device will be used to administer mannitol to healthy subjects and subjects with bronchiectasis in single doses higher than previously given.The main objective is to assess ...
Eligibility Criteria
Inclusion
- healthy or bronchiectatic; 18 years and over
Exclusion
- uncontrolled asthma, unstable
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00730977
Start Date
August 1 2008
End Date
September 1 2008
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Prince Alfred Hospital
Sydney, Australia